PET imaging of PDE4B during major depressive episodes
About this title
Read the official source —[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
[C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
31P-MRS and Resting State Functional Connectivity Analysis of the Effects of 5-hydroxytryptophan and Creatine for Antidepressant Augmentation in Patients With SSRI/SNRI-resistant Major Depressive Disorder
This study evaluates the safety of LB-102 for people with schizophrenia.
Development of a Novel Cannabis Brief Intervention for Frequently-Using Emerging Adults: Pilot Randomized Trial
Implementation and Effectiveness of A Bundled Intervention to End Opioid Overdoses by Increasing Treatment Uptake Post Discharge
A Randomized Controlled Trial Examining Extended-Release Injectable Buprenorphine in Those Who Use High Potency Synthetic Opioids
A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders
A Phase 2, Three-arm, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol (PH94B) Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension
A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
Planning for implementation of a family-based intervention for prevention of HIV, substance use, and mental health problems among Hispanic youth at risk: a community-engaged approach
Read the official source —We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.